Johnson & Johnson Launches Independent Surgical Solutions Company

Published By : 11 Dec 2015 | Published By : QYRESEARCH

Johnson & Johnson announced on Thursday that it has launched an independent company on surgical solutions, with key focus on robotics and other device technologies.

In collaboration with Verily Life Sciences, the newly launched company, called Verb Surgical, was formed in connection with the March 2015 collaboration of Google Life Sciences and Ethicon, a medical devices company from Johnson & Johnson.

Scott Huennekens has been named as the president and chief executive officer at Verb Surgical. Huennekens has been a veteran in the medical devices industry with an experience of more than 20 years. 

Global chairman of Johnson & Johnson Medical Devices Gary Pruden said that the newly formed company has been created in order to empower innovation within the surgical solutions industry.

In a prepared statement, Pruden said that he believed Verb Surgical possesses the ability to transform the future of not just robotic surgery but surgery as a whole. When it comes to the robotics platform, the team has already made remarkable progress by developing platforms for application to be used across a plethora of surgical specialties. 

The new robotics-assisted platform is an example of Verb Surgical’s innovation. Developed by Ethicon, this technology revolves around advanced instrumentation and minimally invasive surgery. 

Over the next few years, Verb Surgical hopes to create an all-inclusive surgical solutions platform that will include best in class medical device technology and leading edge robotic capabilities to serve professionals in the operating room. Verb Surgical’s goal is to create these technologies with the help of hospitals and surgeons so as to achieve greater hospital efficiency, improve access to minimally invasive surgery, and enable better patient outcomes. 

Verb Surgical has the investment support of Johnson & Johnson, Ethicon, and Verily. Verily and Ethicon have both contributed in terms of in-process research and development assets, intellectual property, and other resources such as technological, managerial, and surgical expertise.

The newly formed company will be located in California.

Back To Top